Anson Funds Management LP

Position in YARW — Yarrow Bioscience, Inc.

CIK 1491072 DALLAS, TX

Position in YARW

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$743,377

+$4,234 QoQ

Shares Held

1,243,106

-2.5% QoQ

Ownership

3.73%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Anson Funds Management LP holds $3,230,184 across 4 Biotechnology names. YARW ranks #3 (23.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	44,231	$1,480,853
2	SPRO	Spero Therapeutics, Inc.	421,956	$987,377
3	YARW	Yarrow Bioscience, Inc. This page	1,243,106	$743,377
4	OABIW	OmniAb, Inc.	11,833	$18,577

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$743,377	1,243,106	-2.5%	Shares	Defined	2026-05-19
2025-12-31	$739,143	1,274,386	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.